POST-COVID-19 CONDITION
Clinical trials for POST-COVID-19 CONDITION explained in plain language.
Never miss a new study
Get alerted when new POST-COVID-19 CONDITION trials appear
Sign up with your email to follow new studies for POST-COVID-19 CONDITION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could two old drugs beat long COVID? new trial aims to find out
Disease control Not yet recruitingThis study tests whether two FDA-approved drugs, maraviroc and atorvastatin, can help people with Long COVID. 252 adults aged 18-65 with persistent symptoms will take either the drug combination or a placebo for 16 weeks. The main goal is to see if it reduces fatigue and improves…
Matched conditions: POST-COVID-19 CONDITION
Phase: PHASE2, PHASE3 • Sponsor: HealthBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Oxygen chamber therapy put to the test for dozens of diseases
Disease control Not yet recruitingThis study will test hyperbaric oxygen therapy (HBOT) — breathing pure oxygen in a pressurized chamber — for over 30 conditions, including long COVID, Crohn's disease, frostbite, and multiple sclerosis. Researchers will track 100 patients to see if HBOT improves their quality of …
Matched conditions: POST-COVID-19 CONDITION
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a Plant-Based supplement ease long COVID? new trial aims to find out
Symptom relief Not yet recruitingThis study tests whether a natural supplement (made from orange, grapefruit, olive leaf, and other plant extracts) combined with a personalized exercise program can help people with long COVID. The trial will include 40 adults who still have symptoms like inflammation and fatigue…
Matched conditions: POST-COVID-19 CONDITION
Phase: NA • Sponsor: Universidad Católica San Antonio de Murcia • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Cord blood infusion trial aims to beat long COVID fatigue
Symptom relief Not yet recruitingThis phase 3 trial tests whether a single infusion of human umbilical cord blood, called REGENECYTE, can reduce fatigue in people with Long COVID. Sixty adults with post-COVID condition will receive either the cord blood or a placebo (salt water) and be monitored for changes in f…
Matched conditions: POST-COVID-19 CONDITION
Phase: PHASE3 • Sponsor: StemCyte, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC